Ghiath M. Sukhtian - Net Worth and Insider Trading
Ghiath M. Sukhtian Net Worth
The estimated net worth of Ghiath M. Sukhtian is at least $16 Million dollars as of 2024-11-13. Ghiath M. Sukhtian is the Director, 10% Owner of Outlook Therapeutics Inc and owns about 2,548,253 shares of Outlook Therapeutics Inc (OTLK) stock worth over $16 Million. Details can be seen in Ghiath M. Sukhtian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ghiath M. Sukhtian has not made any transactions after 2021-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ghiath M. Sukhtian
Ghiath M. Sukhtian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ghiath M. Sukhtian owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Ghiath M. Sukhtian’s form 4 insider trades.
Insider Ownership Summary of Ghiath M. Sukhtian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2021-11-29 | director & 10 percent owner |
Ghiath M. Sukhtian Latest Holdings Summary
Ghiath M. Sukhtian currently owns a total of 1 stock. Ghiath M. Sukhtian owns 2,548,253 shares of Outlook Therapeutics Inc (OTLK) as of November 29, 2021, with a value of $16 Million.
Latest Holdings of Ghiath M. Sukhtian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2021-11-29 | 2,548,253 | 6.27 | 15,977,546 |
Holding Weightings of Ghiath M. Sukhtian
Ghiath M. Sukhtian Form 4 Trading Tracker
According to the SEC Form 4 filings, Ghiath M. Sukhtian has made a total of 2 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 800,000 shares on November 29, 2021, which cost Ghiath M. Sukhtian around $20 Million.
Insider Trading History of Ghiath M. Sukhtian
- 1
Ghiath M. Sukhtian Trading Performance
GuruFocus tracks the stock performance after each of Ghiath M. Sukhtian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ghiath M. Sukhtian is 61.82%. GuruFocus also compares Ghiath M. Sukhtian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ghiath M. Sukhtian within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ghiath M. Sukhtian's insider trading performs compared to the benchmark.
Performance of Ghiath M. Sukhtian
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 40.53 | | | | | |
| Relative Return to S&P 500(%) | 38.48 | | | | | |
Ghiath M. Sukhtian Ownership Network
Ownership Network List of Ghiath M. Sukhtian
Ownership Network Relation of Ghiath M. Sukhtian
Ghiath M. Sukhtian Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Ghiath M. Sukhtian is the director & 10 percent owner of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Ghiath M. Sukhtian made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Ghiath M. Sukhtian Mailing Address
Above is the net worth, insider trading, and ownership report for Ghiath M. Sukhtian. You might contact Ghiath M. Sukhtian via mailing address: 7th Circle, Zahran St., Zahran Plaza Building, 4th Floor, Amman M2 11844.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
